Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06805877 · ClinicalTrials.gov registry record · NA

Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing

A NA study of HIV, sponsored by Harvard Pilgrim Health Care.

Active
Registry status
NA
Development phase
16
Enrollment target
16
Study locations

NCT06805877 is a NA study of HIV that is active but no longer recruiting, run by Harvard Pilgrim Health Care. The registered enrollment target is 16 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (96% lower). The trial reports 16 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06805877, a NA study of HIV, is active but no longer recruiting, sponsored by Harvard Pilgrim Health Care.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
16
Study locations

Study Summary

Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the U.S. initiative to end the HIV epidemic, but healthcare providers lack tools to support PrEP discussions and prescribing for patients likely to benefit. This research will evaluate whether integrating automated tools into electronic health records to help providers efficiently and equitably identify potential candidates for PrEP, discuss PrEP, and prescribe PrEP can improve PrEP initiation and persistence in safety-net community health centers. It will achieve this by conducting a stepped-wedge trial of a decision support tool with an embedded HIV prediction model to identify patients likely to benefit from PrEP. The intervention will be delivered to healthcare providers in 16 community health centers within the national OCHIN network.

Conditions Studied

Interventions

  • OTHER Predictive Analytics and Clinical Decision Support

Study Locations (16)

California

  • Bay Area Community Health Liberty Clinic - Fremont
  • Lifelong East Oakland Health Center - Oakland
  • TrueCare Oceanside Family Medicine - Oceanside
  • DAP Legacy - Palm Springs
  • One Community Health Midtown Campus - Sacramento

Massachusetts

  • Lynn Community Health Center 269 Union - Lynn
  • Mattapan Community Health Center Blue Hill - Mattapan

Ohio

  • Neighborhood Family Practice Ridge Community Health Center - Cleveland
  • Signature Health Painesville - Painesville

Connecticut

  • Southwest Community Health Center 968 Fairfield Avenue - Bridgeport

Georgia

  • Mercy Care Decatur Street - Atlanta

Iowa

  • Siouxland Community Health Center Sioux City - Sioux City

Oklahoma

  • Variety Care Sequoyah - Oklahoma City

Oregon

  • Prism Belmont - Portland

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2025-04-21
Est. Completion 2030-07
Phase NA

Sponsor

Harvard Pilgrim Health Care

28 total trials

What the Registry Record Tells You About NCT06805877

The ClinicalTrials.gov registry entry for NCT06805877 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (96% lower). The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Predictive Analytics and Clinical Decision Support is the first listed.

NCT06805877 reports 16 study locations spanning 10 distinct geographic areas - top geographies include California, Massachusetts, Ohio.

Frequently Asked Questions

What is clinical trial NCT06805877 about?

NCT06805877 is a clinical study titled "Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing". Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the U.S. initiative to end the HIV epidemic, but healthcare providers lack tools to support PrEP discussions and prescribing for patients likely to benefit. This research will evaluate whether integrating automated tools into electr...

What is the current status of trial NCT06805877?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-04-21. Estimated completion is 2030-07.

What conditions does trial NCT06805877 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06805877?

The interventions under investigation include: Predictive Analytics and Clinical Decision Support (OTHER).

Who is sponsoring clinical trial NCT06805877?

This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06805877 being conducted?

This trial has 16 study locations across California, Connecticut, Georgia, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.